Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

Eitemau Tebyg

• Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations
  gan: Armin Frille, et al.
  Cyhoeddwyd: (2024-09-01)
• The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy
  gan: Francis Proulx-Rocray, et al.
  Cyhoeddwyd: (2023-01-01)
• Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
  gan: Cristina Julian, et al.
  Cyhoeddwyd: (2023-04-01)
• Synchronous mucinous metaplasia and neoplasia of the female genital tract with both pulmonary metastases and STK11/KRAS gene mutations: a case report
  gan: Ru Wang, et al.
  Cyhoeddwyd: (2023-11-01)
• The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules
  gan: Bin Zhao, et al.
  Cyhoeddwyd: (2024-06-01)